Prologue Research International People News: Art Ziegler Joins Prologue as the New VP, Business Development
Published: Jan 07, 2010
COLUMBUS, OH--(Marketwire - January 07, 2010) -
Prior to joining Prologue, Mr. Ziegler held various positions at Pharmaceutical (Smithkline & French Laboratories), Biotech (Ortho Biotech - JNJ), SMO (Florida Pharmaceutical Research) and CRO (Premier Research) companies. Prologue wholeheartedly welcomes him to the team and looks forward to his guidance as we continue to grow as "The Oncology CRO."
Prologue Research is a leading global oncology contract research organization (CRO) founded in 1998. The Company offers a full range of clinical research services for Phase I-IV international or US-based clinical trials in oncology. Prologue provides its clients with world-class experience, a deeply qualified staff, and state-of-the-art systems uniquely designed for complicated oncology trials. We offer the expertise, service and talent that enables our sponsors to make an impact in the lives of people with cancer.
Dr. Andrew Zupnick
Email: Email Contact